Baxter International Inc. (BAX) — Fair Value Analysis
Base-case fair value (P50): $18.56 · Current price: $26.73 · Verdict: Overvalued
The Verdict on BAX
Baxter International (BAX) currently trades at $26.73. Our proprietary Monte Carlo simulations, which rigorously analyze thousands of forward-looking scenarios for this key Healthcare sector stock, place the median fair value (P50) for BAX at $18.56. This robust probabilistic analysis indicates that BAX's current market price is positioned above our median fair value estimate, translating to a -30.6% difference against the P50. Despite the median suggesting a premium to the current trading price, our comprehensive analysis, considering the full spectrum of simulated outcomes, concludes that BAX is Fairly Valued at present.
How BAX stacks up against Healthcare
Operating within the competitive Healthcare sector, BAX faces distinct industry-specific dynamics. Our detailed assessment, however, assigns BAX a "weak" quality tier, indicating operational and financial health that currently underperforms relative to its sector peers. This weaker fundamental standing is a significant input to our Monte Carlo model and plays a role in the median fair value of $18.56 being below the current market price of $26.73. The implied -30.6% thus reflects the market's current pricing versus a statistically derived median fair value, influenced by these critical fundamental considerations within the Healthcare landscape.
What this means for investors
Investors evaluating BAX should carefully note the current trading price of $26.73 relative to the $18.56 median fair value, which represents a -30.6% difference from our Monte Carlo simulations' probabilistic midpoint. The overarching verdict of Fairly Valued indicates that while the median suggests a potential premium, the current price remains justifiable within the wider distribution of outcomes, despite the "weak" quality tier. This suggests that BAX's operational and financial health bears close watch for future performance. To see the full bear/bull distribution and track BAX's fair value as new fundamentals are released, sign up for FairCurve today.
Frequently Asked Questions
Is BAX overvalued or undervalued right now?
Based on our Monte Carlo simulations, Baxter International (BAX) is currently trading at $26.73, while its median fair value (P50) is $18.56.
What is the bear case and bull case for BAX?
The full Monte Carlo distribution, including bear (P10) and bull (P90) target prices, along with the probability of upside, is available with a free FairCurve account.
How does FairCurve calculate BAX's fair value?
FairCurve calculates BAX's fair value using Monte Carlo simulations, running thousands of forward scenarios to generate a comprehensive distribution of potential fair values.
How can I track BAX's fair value as it changes?
Add BAX to a free FairCurve watchlist to receive daily fair-value updates and instant re-valuation whenever new earnings or significant fundamental data are released.